| 2023年年报 | 2022年年报 | |
|---|---|---|
| 营业收入(元) | ||
| PEEK纯化业务(元) | 40,240,669.73 | 43,239,385.40 |
| PEEK中间体系列产品(元) | 390,804,385.05 | 501,408,247.10 |
| 农药及医药中间体系列产品(元) | 170,752,167.43 | 221,784,595.96 |
| 营业成本(元) | ||
| PEEK纯化业务(元) | 27,588,367.54 | 30,990,997.24 |
| PEEK中间体系列产品(元) | 239,166,004.13 | 360,793,710.84 |
| 农药及医药中间体系列产品(元) | 99,193,958.27 | 153,699,072.51 |
| 毛利(元) | ||
| PEEK纯化业务(元) | 12,652,302.19 | 12,248,388.16 |
| PEEK中间体系列产品(元) | 151,638,380.92 | 140,614,536.26 |
| 农药及医药中间体系列产品(元) | 71,558,209.16 | 68,085,523.45 |
| 毛利率(%) | ||
| PEEK纯化业务(%) | 31.44 | 28.33 |
| PEEK中间体系列产品(%) | 38.80 | 28.04 |
| 农药及医药中间体系列产品(%) | 41.91 | 30.70 |
| 收入构成(%) | ||
| PEEK纯化业务(%) | 6.69 | 5.64 |
| PEEK中间体系列产品(%) | 64.94 | 65.42 |
| 农药及医药中间体系列产品(%) | 28.37 | 28.94 |
| 毛利构成(%) | ||
| PEEK纯化业务(%) | 5.36 | 5.54 |
| PEEK中间体系列产品(%) | 64.29 | 63.64 |
| 农药及医药中间体系列产品(%) | 30.34 | 30.82 |